Forest Investigative Site 1163 — Downington, Pennsylvania

Forest Investigative Site 1163 is a clinical research site located in Downington, Pennsylvania, United States 19335.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 1163 has participated in 1 clinical trials.

Therapeutic areas: Stage 1 Hypertension, Stage 2 Hypertension.

Sponsors: Forest Laboratories.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Downington

Browse all research sites in Pennsylvania · View every site in Downington

• GSK Investigational Site
• Forest Investigative Site 1820
• Brandywine Clinical Research
• Investigational Site Number 840803
• Novartis US
• Pfizer Investigational Site
• Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 1163?

Forest Investigative Site 1163 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 1163 conducted?

Forest Investigative Site 1163 has 1 clinical trials on record. Their work covers Stage 1 Hypertension, Stage 2 Hypertension.

Is Forest Investigative Site 1163 accredited by Crixeo Clinical Trials?

Forest Investigative Site 1163 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 1163?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.